ENO1 and breast carcinoma: Inhibition of the expression of ENO-1 by siRNA enhanced the cytotoxic effects of tamoxifen in tamoxifen-resistant breast cancer cells, rationalizing the use of ENO-1 as a drug target to reverse tamoxifen resistance in breast cancer [243].